Income Taxes (Details) - USD ($) |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Income Taxes [Abstract] | ||||
| Deferred income tax expense | $ 528,480 | $ 288,000 | $ 576,000 | $ 576,000 |
| Valuation allowance increased | 4,928,000 | $ 4,043,000 | ||
| Federal net operating loss carryforward | 28,700,000 | |||
| Federal research and development | $ 1,035,000 | |||
| X | ||||||||||
- Definition Federal net operating loss carryforward. No definition available.
|
| X | ||||||||||
- Definition Federal research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|